Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 4Unknown 3

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 72Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Leukemia, Myelomonocytic, Acute 24Leukemia, Monocytic, Acute 22Leukemia, Erythroblastic, Acute 22Leukemia, Megakaryoblastic, Acute 20Congenital Abnormalities 18Myelodysplastic Syndromes 10Lymphoma 10Anemia, Refractory, with Excess of Blasts 10Burkitt Lymphoma 8Leukemia, Eosinophilic, Acute 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Basophilic, Acute 6Myeloproliferative Disorders 5Leukemia, Biphenotypic, Acute 5Leukemia, Promyelocytic, Acute 4Dendritic Cell Sarcoma, Interdigitating 4Thrombocytopenia 3Neoplasm, Residual 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Recurrence 2Philadelphia Chromosome 2Neutropenia 2Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Cytarabine 16Arsenic Trioxide 11Tretinoin 10Methotrexate 10Cyclophosphamide 9Idarubicin 8Filgrastim 7Mercaptopurine 6Busulfan 6fludarabine phosphate 5Etoposide 5Vorinostat 4Topotecan 4Sorafenib 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Daunorubicin 4Clofarabine 4Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3Azacitidine 3Antilymphocyte Serum 3romidepsin 2merphos 2lintuzumab 2entinostat 2Thiotepa 2Tacrolimus 2Mitoxantrone 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Leukemia, Promyelocytic, Acute × Daunorubicin × Clear all
NCT00005962 2023-06-22

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Eastern Cooperative Oncology Group

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT01253070 2022-08-04

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00276601 2014-04-17

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003934 2013-06-05

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
420 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡